4.70 USD
↗ 0.37 (8.55%)AT CLOSE (11:59 AM EDT)
Passage Bio, Inc. Common Stock
PASGNASDAQ • USD
4.63
↘ 0.08 (1.60%)
POST MARKET (AS OF 05:00 PM EDT)
Post Market
AS OF 05:00 PM EDT
4.63
↘ 0.08 (1.60%)
Market: OPEN
Shares of Passage Bio, Inc. Common Stock (PASG) are trading at $4.63. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest PASG is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 26, 2026.
Open?$4.30
High?$5.00
Low?$4.19
Prev. Close?$4.33
Volume?279.0K
Avg. Volume?100.9K
VWAP?$4.71
Rel. Volume?2.76x
Bid / Ask
Bid?$3.87 × 100
Ask?$5.70 × 100
Spread?$1.83
Midpoint?$4.79
Valuation & Ratios
Market Cap?13.9M
Shares Out?3.2M
Float?2.8M
Float %?88.7%
P/E Ratio?N/A
P/B Ratio?1.18
EPS?-$11.73
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Themes
Employees
24
Market Cap
13.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-02-28
Address
ONE COMMERCE SQUARE
PHILADELPHIA, PA 19103
Phone: (267) 866-0312
PHILADELPHIA, PA 19103
Phone: (267) 866-0312
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?85
Piotroski F-Score?0/9Weak
Altman Z-Score?-30.31Distress
Confidence?40%Low
Short InterestLow
Short % of Float?3.26%Low
Short Interest?92.6K
Days to Cover?2.6
Free Float2.8M
Avg Daily Volume36.2K
Settlement Date2026-06-15
Financial Health
Current Ratio?1.73Adequate
Quick Ratio?1.73Adequate
Cash Ratio?1.66Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.18CHEAP▾
Peers100
S&P93
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.5CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-320.6%WEAK▾
S&P3
ROA?-103.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-19424533
Fundamentals ratios updated end of day